AIM: FIPP
12 October 2026
Frontier IP Group Plc
("Frontier IP" or the "Group")
Exercise of Options and Total Voting Rights
Frontier IP (AIM: FIPP), a specialist in commercialising intellectual property, announces that a former director of the Company has exercised options to acquire 310,152 new ordinary shares of 10 pence each in the Company ("Ordinary Shares") pursuant to the terms of the Company's Employee Share Option Scheme 2011. These options were awarded in three different tranches on the following dates: 15 November 2018 (89,000 options), 6 December 2019 (173,333 options) and 5 November 2020 (47,819 options) and all options have an exercise price of 10p.
Accordingly, application has been made for 310,152 new Ordinary Shares to be admitted to trading on AIM (“Admission”). Admission is expected to occur at 8.00 a.m. on or around 13 October 2026.
The new Ordinary Shares will rank pari passu with the existing shares of the Company. Following Admission, the Company will have 112,615,058 Ordinary Shares in issue, with one voting right per Ordinary Share. The Company does not hold any Ordinary Shares in treasury, therefore the total number of voting rights in the Company is 112,615,058. Accordingly, the figure of 112,615,058 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA’s Disclosure Guidance and Transparency Rules
ENDS
ENQUIRIES
|
Frontier IP Group Plc Neil Crabb, Chief Executive Andrew Johnson, Communications & Investor Relations Company website: www.frontierip.co.uk |
M: 07415 888 425 |
|
Allenby Capital Limited (Nominated Adviser and Joint Broker) Nick Athanas / David Asquith (Corporate Finance) Joscelin Pinnington / Matt Butlin (Corporate Broking) |
T: 0203 328 5656 |
|
Shore Capital (Joint Broker) Henry Willcocks (Corporate Broking) James Thomas / George Payne (Corporate Advisory) |
T: 0207 408 4050 |
About Frontier IP
Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs.
The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.